Minocycline foam, 1.5%, was approved by the US Food and Drug Administration (FDA) in 2020 for rosacea, and minocycline gel is under investigation as a potential treatment. For patients who can ...

A low-dose (40 mg) modified formulation of minocycline hydrochloride (DFD-29) was better tolerated and more effective than doxycycline and placebo in patients with moderate to severe ...

An increasing amount of evidence suggests that the FDA-approved antibiotic minocycline might have neuroprotective effects in animal models of various neurodegenerative disorders, and Gordon et al.